HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program

被引:8
作者
Ndenkeh, Jackson Jr Nforbewing [1 ,2 ]
Bowring, Anna L. [3 ,4 ]
Njindam, Iliassou Mfochive [4 ]
Folem, Romeo Dongfack [1 ]
Fako, Guy Christian Hendji [1 ]
Ngueguim, Florent Gnintedem [1 ]
Gayou, Oscar Leyou [1 ]
Lepawa, Kelly [5 ]
Minka, Christine Minka [1 ]
Batoum, Christine Manyo [1 ]
Georges, Sandra [1 ]
Temgoua, Edith [6 ]
Nzima, Valery [7 ]
Kob, David Anouar [7 ]
Akiy, Zacheus Zeh [7 ]
Philbrick, William [8 ]
Levitt, Daniel [8 ]
Curry, Dora [8 ]
Baral, Stefan
机构
[1] Care Int Cameroon, Yaounde, Cameroon
[2] Ludwig Maximilian Univ Munich, Univ Hosp, CIHLMU Ctr Int Hlth, Munich, Germany
[3] Burnet Inst, Melbourne, Vic, Australia
[4] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[5] Care & Hlth Program CHP, Yaounde, Cameroon
[6] Natl AIDS Control Comm NACC, Yaounde, Cameroon
[7] US Agcy Int Dev USAID, Yaounde, Cameroon
[8] CARE USA, Atlanta, GA USA
基金
英国医学研究理事会;
关键词
HIV prevention; PrEP; key populations; men who have sex with men; female sex workers; Cameroon; CISGENDER MEN; SEX; PREVENTION; INTERVENTIONS; CABOTEGRAVIR; INFECTION; MODELS; WOMEN; PREP; CARE;
D O I
10.1097/QAI.0000000000003012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Pre-exposure prophylaxis (PrEP) is proven to be a highly effective HIV prevention method for key populations. However, its scale-up in resource-limited settings remains suboptimal. This paper seeks to describe PrEP initiation and continuation among key populations in Cameroon. Methodology: From June 2019 through October 2020, we collected routine program data on PrEP uptake and continuation among female sex workers (FSWs) and men who have sex with men (MSM) in the Continuum of prevention, care and treatment of HIV/AIDS with Most-at-risk Populations (CHAMP) program in Cameroon. PrEP was offered to clients who tested negative for HIV and were assessed to potentially benefit from PrEP. Using survival analysis, we identified factors associated with PrEP discontinuation over time with significance set at 5%. Results: Overall, 27,750 clients were sensitized for PrEP of whom 3,138 persons were eligible to start PrEP and 1,409 (45%; FSW: 691 and MSM: 718) initiated PrEP. The PrEP continuation rate was 37% at 3 months, 28% at 6 months and 19% at 12 months. PrEP discontinuation was significantly higher among FSW than MSM [adjusted hazard ratio (aHR) 1.5 (95% CI: 1.2 to 1.9)] in Yaounde [aHR 1.5 (95% CI: 1.2 to 1.9)] and Bafoussam/Bertoua [aHR 3.1 (2.2-4.5)] relative to Douala. Discontinuation was lower among those with moderate [aHR 0.3 (0.3-0.4)] or good adherence [aHR 0.4 (0.3-0.6)] compared with poor adherence (all P < 0.001). Conclusion: Differentiated approaches to deliver PrEP, create demand, and provide more intensive support for adherence and continuation may support scale-up of PrEP in Cameroon for equitable and prolonged impact on HIV prevention.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 68 条
  • [1] A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up
    Anand, Tarandeep
    Nitpolprasert, Chattiya
    Trachunthong, Deondara
    Kerr, Stephen J.
    Janyam, Surang
    Linjongrat, Danai
    Hightow-Weidman, Lisa B.
    Phanuphak, Praphan
    Ananworanich, Jintanat
    Phanuphak, Nittaya
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20
  • [2] [Anonymous], 2020, FACT SHEET GLOB HIV
  • [3] [Anonymous], 2015, CAR TREATM HIV AIDS
  • [4] [Anonymous], 2018, HIV RES PREVENTION C
  • [5] [Anonymous], 2019, KEY POPULATION LED H
  • [6] [Anonymous], 2016, CONSOLIDATED GUIDELI
  • [7] Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
    Baeten, J. M.
    Palanee-Phillips, T.
    Brown, E. R.
    Schwartz, K.
    Soto-Torres, L. E.
    Govender, V.
    Mgodi, N. M.
    Kiweewa, F. Matovu
    Nair, G.
    Mhlanga, F.
    Siva, S.
    Bekker, L. -G.
    Jeenarain, N.
    Gaffoor, Z.
    Martinson, F.
    Makanani, B.
    Pather, A.
    Naidoo, L.
    Husnik, M.
    Richardson, B. A.
    Parikh, U. M.
    Mellors, J. W.
    Marzinke, M. A.
    Hendrix, C. W.
    van der Straten, A.
    Ramjee, G.
    Chirenje, Z. M.
    Nakabiito, C.
    Taha, T. E.
    Jones, J.
    Mayo, A.
    Scheckter, R.
    Berthiaume, J.
    Livant, E.
    Jacobson, C.
    Ndase, P.
    White, R.
    Patterson, K.
    Germuga, D.
    Galaska, B.
    Bunge, K.
    Singh, D.
    Szydlo, D. W.
    Montgomery, E. T.
    Mensch, B. S.
    Torjesen, K.
    Grossman, C. I.
    Chakhtoura, N.
    Nel, A.
    Rosenberg, Z.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) : 2121 - 2132
  • [8] Demand creation for primary biomedical prevention: identifying lessons across interventions to inform daily oral preexposure prophylaxis programs
    Bass, Emily
    Fitch, Laura
    Gomez, Anabel
    Loar, Rebecca
    [J]. CURRENT OPINION IN HIV AND AIDS, 2019, 14 (01) : 28 - 40
  • [9] Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake
    Begg, Lorna
    Brodsky, Rebecca
    Friedland, Barbara
    Mathur, Sanyukta
    Sailer, Jim
    Creasy, George
    [J]. BMJ SEXUAL & REPRODUCTIVE HEALTH, 2021, 47 (03) : 166 - 172
  • [10] Bowring A, 2019, 10 IAS C HIV SCI